Savara (SVRA) Non-cash Items (2013 - 2026)
Savara (SVRA) reported Non-cash Items of $11.6 million for Q1 2026, down 28.83% year-over-year from $16.3 million in Q1 2025, and up 38.69% on a QoQ basis from $8.4 million in Q4 2025.
Savara (SVRA) has 14 years of Non-cash Items data on file, last reported at $11.6 million in Q1 2026.
- Quarterly Non-cash Items fell 28.83% year-over-year to $11.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.6 million (down 28.83% YoY) and the FY2025 annual result came in at $8.4 million, down 27.81% from the prior year.
- Non-cash Items improved to $11.6 million in Q1 2026 per SVRA's latest filing, from $8.4 million in the prior quarter.
- Across five years, Non-cash Items topped out at $25.4 million in Q4 2023 and bottomed at $1.2 million in Q1 2022.
- The 5-year median for Non-cash Items is $7.2 million (2024), against an average of $7.8 million.
- The widest annual swing landed in 2023, when Non-cash Items jumped 1663.33%; it then tumbled 54.37% in 2024.
- Tracing SVRA's Non-cash Items over 5 years: stood at $1.4 million in 2022, then jumped by 1663.33% to $25.4 million in 2023, then plunged by 54.37% to $11.6 million in 2024, then declined by 27.81% to $8.4 million in 2025, then jumped by 38.69% to $11.6 million in 2026.
- Per Business Quant, the three latest SVRA Non-cash Items figures stand at $11.6 million (Q1 2026), $8.4 million (Q4 2025), and $5.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Savara | 1.30 Bn | 1.30 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.60 Mn |
| Mar 31, 2026 | 11.60 Mn |
| Dec 31, 2025 | 8.36 Mn |
| Dec 31, 2025 | 8.36 Mn |
| Sep 30, 2025 | 5.30 Mn |
| Sep 30, 2025 | 5.30 Mn |
| Jun 30, 2025 | 15.40 Mn |
| Jun 30, 2025 | 15.40 Mn |
| Mar 31, 2025 | 16.30 Mn |
| Mar 31, 2025 | 16.30 Mn |
| Dec 31, 2024 | 11.59 Mn |
| Dec 31, 2024 | 11.59 Mn |
| Sep 30, 2024 | 7.20 Mn |
| Sep 30, 2024 | 7.20 Mn |
| Jun 30, 2024 | 7.60 Mn |
| Jun 30, 2024 | 7.60 Mn |
| Mar 31, 2024 | 8.30 Mn |
| Mar 31, 2024 | 8.30 Mn |
| Dec 31, 2023 | 25.39 Mn |
| Dec 31, 2023 | 25.39 Mn |
| Sep 30, 2023 | 4.70 Mn |
| Sep 30, 2023 | 4.70 Mn |
| Jun 30, 2023 | 1.80 Mn |
| Jun 30, 2023 | 1.80 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | 1.44 Mn |
| Dec 31, 2022 | 1.44 Mn |
| Sep 30, 2022 | 2.30 Mn |
| Sep 30, 2022 | 2.30 Mn |
| Jun 30, 2022 | 2.70 Mn |
| Jun 30, 2022 | 2.70 Mn |
| Mar 31, 2022 | 1.20 Mn |
| Mar 31, 2022 | 1.20 Mn |
| Dec 31, 2021 | 354,000.00 |
| Dec 31, 2021 | 354,000.00 |
| Dec 31, 2020 | 190,000.00 |
| Dec 31, 2020 | 190,000.00 |
| Dec 31, 2019 | 461,000.00 |
| Dec 31, 2019 | 461,000.00 |
| Dec 31, 2018 | 7.98 Mn |
| Dec 31, 2018 | 7.98 Mn |
| Dec 31, 2017 | 22.50 Mn |
| Dec 31, 2017 | 22.50 Mn |
| Mar 31, 2017 | 2.10 Mn |
| Mar 31, 2017 | 2.10 Mn |
| Dec 31, 2016 | 13.87 Mn |
| Dec 31, 2016 | 13.87 Mn |
| Sep 30, 2016 | 4.80 Mn |
| Sep 30, 2016 | 4.80 Mn |
| Jun 30, 2016 | 5.30 Mn |
| Jun 30, 2016 | 5.30 Mn |
| Mar 31, 2016 | 5.90 Mn |
| Mar 31, 2016 | 5.90 Mn |
| Dec 31, 2015 | 10.43 Mn |
| Dec 31, 2015 | 10.43 Mn |
| Sep 30, 2015 | 4.80 Mn |
| Sep 30, 2015 | 4.80 Mn |
| Jun 30, 2015 | 5.20 Mn |
| Jun 30, 2015 | 5.20 Mn |
| Mar 31, 2015 | 4.40 Mn |
| Mar 31, 2015 | 4.40 Mn |
| Dec 31, 2014 | 374,000.00 |
| Dec 31, 2014 | 374,000.00 |
| Sep 30, 2014 | 4.00 Mn |
| Sep 30, 2014 | 4.00 Mn |
| Jun 30, 2014 | 5.30 Mn |
| Jun 30, 2014 | 5.30 Mn |
| Mar 31, 2014 | 3.10 Mn |
| Mar 31, 2014 | 3.10 Mn |
| Dec 31, 2013 | 2.60 Mn |
| Dec 31, 2013 | 2.60 Mn |